Rhythm Pharmaceuticals, Inc. (RYTM)
87.21
+0.37
(+0.43%)
USD |
NASDAQ |
May 19, 16:00
87.21
0.00 (0.00%)
After-Hours: 19:14
Rhythm Pharmaceuticals Research and Development Expense (Quarterly) : 41.67M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 2.410M |
| Sarepta Therapeutics, Inc. | 153.96M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| Biogen, Inc. | 471.10M |
| MannKind Corp. | 17.23M |